FDA.reportPublic FDA data

moxetumomab pasudotox-tdfk 1 MG Injection

RxCUI
2099309
RxNorm name
moxetumomab pasudotox-tdfk 1 MG Injection
Display name
moxetumomab pasudotox-tdfk 1 MG Injection
Full name
moxetumomab pasudotox-tdfk 1 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761104Lumoxitimoxetumomab pasudotox-tdfk351(a)Disc2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
8ddffb08-aab1-41f5-bbc6-09457e4e80camoxetumomab pasudotox-tdfk 1 MG InjectionPSN2These highlights do not include all the information needed to use LUMOXITI safely and effectively. See full prescribing information for LUMOXITI. LUMOXITI ® (moxetumomab pasudotox-tdfk) for injection, for intravenous use Initial U.S. Approval: 201820200903
8ddffb08-aab1-41f5-bbc6-09457e4e80camoxetumomab pasudotox-tdfk 1 MG InjectionSCD2These highlights do not include all the information needed to use LUMOXITI safely and effectively. See full prescribing information for LUMOXITI. LUMOXITI ® (moxetumomab pasudotox-tdfk) for injection, for intravenous use Initial U.S. Approval: 201820200903